vimarsana.com

Page 338 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brandywine Realty Trust (NYSE:BDN) Receives New Coverage from Analysts at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft initiated coverage on shares of Brandywine Realty Trust (NYSE:BDN – Free Report) in a research report report published on Tuesday morning, MarketBeat.com reports. The firm issued a hold rating and a $5.50 price objective on the real estate investment trust’s stock. A number of other research analysts also recently commented on the […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews com

StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Performance Shares of NASDAQ:BCLI opened at $0.39 on Wednesday. Brainstorm Cell Therapeutics has a one year low of $0.13 […]

Redwire (NYSE:RDW) Receives New Coverage from Analysts at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Redwire (NYSE:RDW – Free Report) in a research note released on Friday, MarketBeat.com reports. The firm issued an overweight rating and a $5.00 price target on the stock. Separately, Alliance Global Partners initiated coverage on shares of Redwire in a research note on Wednesday, December 20th. They set […]

Cedar Fair (NYSE:FUN) Now Covered by StockNews com

Analysts at StockNews.com initiated coverage on shares of Cedar Fair (NYSE:FUN – Get Free Report) in a research report issued on Thursday. The brokerage set a “buy” rating on the stock. Other analysts have also recently issued research reports about the stock. Truist Financial upped their target price on shares of Cedar Fair from $44.00 […]

XBiotech (NASDAQ:XBIT) Now Covered by Analysts at StockNews com

StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Up 17.3 % Shares of XBiotech stock opened at $5.43 on Tuesday. XBiotech has a 12 month low of $3.05 and a 12 month […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.